Multisystem Inflammatory Syndrome in Children (MIS-C): A Brazilian epidemiological analysis
DOI:
https://doi.org/10.33448/rsd-v10i9.18154Keywords:
Covid-19; Epidemiology; Pediatrics; Multisystemic inflammatory syndrome; Brazil.Abstract
This article aimed to analyze the Brazilian epidemiological context of pediatric multisystemic inflammatory syndrome (MIS-C) temporally associated with Covid-19. Therefore, a statistical and descriptive study was carried out, guided by the interpretation of data collected on the platforms of the Health Departments of the 27 federative units in the country and covering the period between the first confirmed case of the syndrome, in 2020, until june 2021. The parameters investigated were about the total number of cases and deaths, as well as the distribution between states, sexes and age groups. There were 1010 diagnoses and 65 deaths triggered by the syndrome, indicating a fatality rate of 6.4%. 55.4% of the cases were described in males, while deaths, in turn, were more common in girls, representing approximately 76% of the verified deaths. The age group most affected by SIM-P was between 0 and 4 years of age. Most cases and deaths caused by the syndrome occurred in the Southeast region, especially in the state of São Paulo, which accounted for 19.1% of all diagnoses and 18.4% of all deaths in Brazil. SIM-P represents a serious condition associated with SARS-CoV-2 infection and, therefore, requires caution on the part of children, adolescents and their families regarding the proper adoption of preventive measures recommended for Covid-19. Although this is a recent topic, the numbers already reported in the country are sufficient for pediatricians and general practitioners to obtain the necessary medical knowledge for the early diagnosis of this syndrome, allowing for the reduction of negative outcomes and a better prognosis.
References
Centro de Vigilância Epidemiológica. Vigilância Epidemiológica da Síndrome Inflamatória Multissistêmica Pediátrica (SIM-P), temporalmente associada à COVID-19 no Estado de São Paulo, Semanas Epidemiológicas 01/2020 a 06/2021. Boletim Epidemiológico, 1, 11, 1-6. Recuperado de: https://docs.bvsalud.org/biblioref/2021/02/1148042/boletim11se6_simp.pdf.
De Alencar, M. F. R, Veloso, W. G., Bezerra, R. E. A., Gomes, L. A. & Marcolino, A. B. L. (2021). O impacto da pandemia do covid-19 na saúde infanto-juvenil: um estudo transversal. Brazilian Journal of Health Review, 4, 1, 3483-3497.
Esposito, S. & Principi, N. (2020). To mask or not to mask children to overcome COVID-19. European Journal of Pediatrics, 179, 8, 1267–1270.
Esposito, S. & Principi, N. (2021). Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Pediatric Drugs, 23, 119-129.
Feldstein, L. R., Rose, L. B., Horwitz, S. M., Collins, J. P., Newhans, M. M., Son, M. B. F., Newburger, J. W., Kleinman, L. C., Heidemann, S. M., Martin, A. A., Singh, A. R. & Li, S. (2020). Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. The New England Journal of Medicine, 383, 334-346. doi: 10.1056/NEJMoa2021680
Ferreira, B. W. R. C., Gusmão, A. B., de Leon, P. A. P., Ferreira, R. K. G. & Macedo, C. L. (2021). Síndrome Inflamatória Multissistêmica Pediátrica (SIM-P) temporariamente associada à COVID-19: um levantamento das características clínicas e epidemiológicas. Research, Society and Development, 10, 3, e5710313020
Fiocruz (2021). Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernando Figueira. Covid-19 e saúde da criança e do adolescente, 1-70.
Fontes, L. G. M., Saavedra, R. C., Carvalho, J. M. A., Broucke, V. R. B. V., Araújo, F. A. & Menezes, G. A. (2021). Síndrome Inflamatória Multissistêmica Pediátrica (SIM-P) na Bahia, em 2020. Revista Baiana de Saúde Pública, 45(1), 46-61.
Godfred-Cato, S., Bryant, B., Leung, J., Oster, M. E., Conklin, L., Abrams, J., Roguski, K., Wallace, B., Prezzato, E., Koumans, E. H., Lee, E. H., Geevarughese, A., Lash, M. K., Reilly, K. H., Pulver, W. P., Thomas, D., Feder, K. A., Hsu, K. K., Plipat, N., Richardson, G., Reid, H., Lim, S., Schmitz, A., Pierce, T., Hrapcak, S., Datta, D., Morris, S. B., Clarke, K. & Belay, E. (2020). COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020. Morbidity and Mortality Weekly Report, 69, 32, 1074-1080.
Instituto Butantã (2021). CoronaVac é segura e gera forte resposta imune em crianças e adolescentes, confirma estudo. Recuperado de: https://butantan.gov.br/noticias/coronavac-e-segura-e-gera-forte-resposta-imune-em-criancas-e-adolescentes-confirma-estudo
Hasan, M. R., Al Zubaidi, K., Diab, K., Hejazi, Y., Bout-Tabaju, S., Al-Adba, B., Al Maslamani, E., Janahi, M., Roscoe, D., Lopez, A. P. & Tang, P. (2021). COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar. BMC Pediatrics, 21, 267.
Hennon, T. R., Penque, M. D., Abdul-Aziz, R., Alibrahim, O. S., McGreevy, M. B., Prout, A. J., Schaefer, B. A., Ambrusko, S. J., Pastore, J. V., Turkovich, S. J., Gomez-Duarte, O. G., & Hicar, M. D. (2020). COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach. Progress in pediatric cardiology, 101232.
Lima-Setta, F., Magalhães-Barbosa, M. C., Rodrigues-Santos, G., Figueiredo, E., Jacques, M. L., Zeitel, R. S., Sapolnik, R., Borges, C., Lanziotti, V. S., Castro, R., Bellinat, A., Silva, T., Oliveira, F., Reis, B., Castro, N., Macedo, J., Scarlato, A., Riveiro, P. M., Mota, I., Lorenzo, V. B., de Lucena, N. M. L., Azevedo, Z. M. A., Cunha, A. J. L. A. & Prata-Barbosa, A. (2021). Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study. Jornal de pediatria, 97, 3, 354–361.
Martins, G. M. V., Rangel, S. S., Eduardo, M. P., Rosário, I. R. A. S. & Dias, E. C. C.. A. (2020). Síndrome Inflamatória Multissistêmica Pediátrica Associada ao COVID-19. Revista Científica da FMC, 15, 3, 77-81.
Ministério da Saúde, M. S. (2021). Secretaria de Vigilância em Saúde. Boletim Epidemiológico, 52, 23. Recuperado de: https://www.gov.br/saude/pt-br/media/pdf/2021/junho/21/boletim_epidemiologico_svs_23.pdf
Ministério da Saúde, M. S. (2021). Painel Coronavírus. Coronavírus Brasil. Recuperado de: https://covid.saude.gov.br/
Ministério da Saúde, M. S. (2021). Vacinômetro. Recuperado em: https://www.gov.br/saude/pt-br/vacinacao
Morris, S. B., Schwartz, N. G., Patel, P., Abbo, L., Beauchamps, L., Balan, S., Lee E. H., Paneth-Pollak, R., Geevarughese, A., Lash, M. K., Dorsinville M. S., Ballen, V., Eiras, D. P., Newton-Cheh, C., Smith, E., Robinson, S., Stogsdill, P., Lim, S., Fox, S. E., Richardson, G., Hand, J., Oliver, N. T., Kofman, A., Bryant, B., Ende, Z., Datta, D., Belay, E., & Godfred-Cato, S. (2020). Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March–August 2020. Morbidity and Mortality Weekly Report, 69, 40, 1450.
Nakara, N. A., Blumberg, D. A., Herrera-Guerra, A., & Lakshminrusimha, S. (2020). Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children (Basel, Switzerland), 7, 7, 69.
Organização Mundial da Saúde (2020). Virtual press conference on COVID-19 - 11 march 2020. Recuperado de: https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf
Parsons, E., Timlin, M., Starr, C., Fries, A., Wells, R., Studer, M. & Sainato, R. (2021). Multisystem Inflammatory Syndrome in Children in February 2020 and Implications of Genomic Sequencing for SARS-CoV-2. Journal of the Pediatric Infectious Diseases Society, 10, 5, 695–697.
Passarinho, N. & Barrucho, L. (2021). As crianças mortas por Covid no Brasil: “Meu filho poderia ter sobrevivido se tivesse sido testado”. BBC News Brasil. Recuperado de: https://www.bbc.com/portuguese/geral-56775977
Payne, A. B., Gilani, Z., Godfred-Cato, S., Belay, E. D., Feldstein, L. R., Patel, M. M., Randolph, A. G., Newhams, M., Thomas, D., Magleby, R., Hsu, K., Burns, M., Dufort, E., Maxted, A., Pietrowski, M., Longenberger, A., Bidol, S., Henderson, J., Sosa, L., Edmundson, A., Tobin-D'angelo, M., Edison, L., Heidemann, S., Singh, A. R., Giuliano, J. S., Kleinman, L. C., Tarquinio, K. M., Carrol, C. L., Hoots, B. E., Reed, C., Dahlgren, F. S., Oster, M. E., Pierce, T. J., Curns, A. T., Langley, G. E., Campbell, A. P., Balachandran, N., Murray, T. S., Burkholder, C., Brancard, T., Lifshitz, J., Leach, D., Charpie, I., Tice, C., Coffin, S. E., Perella, D., Jones, K., Marohn, K. L., Yager, P. H., Fernandes, N. D., Flori, H. R., Konicki, M. L., Walker, K. S., Di Pentima, M. C., Li, S., Horwitz, S. M., Gaur, S., Coffey, D. C., Harwayne-Gidansky, I., Hymes, S. R., Thomas, N. J., Ackerman, K. G. & Cholette, J. M. (2021). Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. JAMA Network Open, 4, 6, e2116420.
Pereira, M. F. B., Litvinov, N., Farhat, S. C. L., Eisencraft, A. P., Gibelli, M. A. B. C., Carvalho, W. B., Fernandes, V. R., Fink, T. T., Framil, J. V. S., Galleti, K. V., Fante, A. L., Fonseca, M. F. M., Watanabe, A., Paula, C. S. Y., Palandri, G. G., Leal, G. N., Diniz, M. F. R., Pinho, J. R. R. & Silva, C. A. (2020). Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome. Clinics, 75.
Rowley A. H. (2020). Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nature reviews. Immunology, 20, 8, 453–4.
Sáfadi, M. A. P (2020). As características intrigantes da COVID-19 em crianças e seu impacto na pandemia. Jornal de Pediatria, 96, 3, 265-268.
Sociedade Brasileira de Pediatria (2020). Síndrome inflamatória multissistêmica em crianças e adolescentes provavelmente associada à COVID-19: uma apresentação aguda, grave e potencialmente fatal. Departamento Científico de Infectologia. Recuperado de: https://www.sbp.com.br/fileadmin/user_upload/22532d-NA_Sindr_Inflamat_Multissistemica_associada_COVID19.pdf
Silva, J. R. A. (2020). Covid-19 em pediatria: um panorama entre incidência e mortalidade. Residência Pediátrica, 10, 3, 1-4.
Simon, H. J., Sakano, T., Rodrigues, R. M., Eisencraft, A. P., Carvalho, V., Schvartsman, C., & Reis, A. (2021). Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view. Jornal de Pediatria, 97, 2, 140–159.
Torres, J. P., Izquierdo, G., Acuña, M., Pavez, D., Reyes, F., Fritis, A., González, R., Rivacoba, C., Contardo, V. & Tapia, L. I. (2020). Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic. IJID: official publication of the International Society for Infectious Diseases, 100, 75–81.
Whittaker, E., Bamford, A., Kenny, J., Kaforou, M., Jones, C. E., Shah, P., Ramnarayan, P., Fraisse, A., Miller, O., Davies, P., Kucera, F., Brierley, J., McDougall, M., Carter, M., Tremoulet, A., Shimizu, C., Herberg, J., Burns, J. C., Lyall, H. & Levin, M. (2020). Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA, 324, 3, 259–269.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Murilo Luiz Louzada Brandão; Fernanda Odete Souza Rodrigues; Lidiane Bernardo Gomes; Edson Luiz Brandão Netto; Brenda Nayara Gontijo de Moura ; Bianca Cardoso Lopes; Rafael Vinícius de Assis Menezes; Leonardo Alexandre do Amaral; Brenio Felipe Batista Pereira; Thaís Fernandes Campos; Isadora Porto de Aquino; Déborah Luiza Vilela de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
